Novocure

Novocure is a global oncology company that specializes in the development and commercialization of innovative therapies for the treatment of solid tumors. They make money primarily through the sale of their proprietary Tumor Treating Fields (TTFields) devices, which use electric fields to disrupt cancer cell division. Founded in 2000, Novocure has made significant strides in cancer treatment, particularly with their FDA-approved Optune system for glioblastoma. The company is headquartered in Jersey, Channel Islands, and continues to expand its research and development efforts to address various types of cancer.

Recent Posts by Novocure

1-20 of 274